Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
screening
100%
testing
64%
implementation
64%
populations
48%
netherlands
44%
data
40%
aneuploidy
36%
learning
32%
uptake
32%
evaluation
32%
women
29%
values
18%
pregnancy
17%
chromosomal aberrations
17%
obstetrics
16%
origin
16%
attitudes
16%
phenotype
16%
mosaicism
16%
laboratories
12%
malignancies
12%
hypoiodous acid
10%
birth
8%
abnormalities (chromosomal)
8%
surveys
8%
information
8%
weight
8%
comparative evaluations
8%
risks
7%
Medicine and Dentistry
Chromosome Aberration
42%
Mosaicism
42%
First Trimester Pregnancy
42%
Pregnant Woman
36%
Aneuploidy
32%
Trisomy 21
32%
Screening Test
32%
Trisomy
32%
Galactosialidosis
32%
Obstetrics
21%
Cancer
21%
Counseling
21%
Screening Program
15%
Isoniazid
10%
Prenatal Formula
10%
Pre-Eclampsia
10%
Cohort Analysis
10%
Trisomy 18
10%
Invasive Diagnostics
10%
Birth Weight
10%
Prenatal Care
10%
Trisomy 13
10%
Diagnosis
10%
Prenatal Screening
9%
Skin Edema
5%
Cordocentesis
5%
Keyphrases
Noninvasive Prenatal Testing
64%
Additional Findings
38%
National Implementation
32%
Clinical Impact
32%
Screening Test
32%
Galactosialidosis
32%
Positive Predictive Value
25%
Trisomy 21
19%
Pregnant Women
18%
First Year
12%
Chromosomal Aberrations
11%
Counseling
11%
Confined Placental Mosaicism
10%
Obstetric Population
10%
Common Trisomies
10%
Clinical Phenotype
10%
General Obstetrics
10%
Dutch
6%
Clinical Laboratory
6%
Structural Chromosomal Aberrations
6%
Clinically Significant
6%
Maternal Malignancy
6%
Invasive Diagnostic Procedures
6%
Combined Test
6%
Clinical Data
6%
Ministry of Health
6%
Prenatal Care
6%
Parental Anxiety
6%
Trisomy 13
6%
First Trimester
6%
